Posted on August 1, 2017
Bristol-Meyers Squibb’s Opdivo (nivolumab) has just been approved by the FDA for patients with a microsatellite instability-high tumors (also known as MSI-H) or mismatched repair deficiency (dMMR). The approval was specifically for patients whose cancer has progressed following Fluoropyrimidine, Oxaliplatin, and Irinotecan.
Opdivo joins Merck’s Keytruda (pembrolizumab) as the second immunotherapy drug to be approved within four months. Here’s what you need to know. Read more
Posted on July 27, 2017
We can’t thank you enough for your support of the Undy Run/Walk and that’s why we wanted you to be the first to know about the latest and greatest Undy Participant enhancement! Read more
Posted on June 27, 2017
The revolution has officially begun.
With Keytruda, we see a drug that treats different kinds of cancer with the same genetic profile. This is called being tumor agnostic. In short, it doesn’t matter where your tumor is located (colon, breast, lung, etc.), but what genetic markers it contains.
This has the potential to radically change how we see and treat cancers. Read more
Posted on May 16, 2017
Recently, we asked our Facebook community if they’ve experienced what’s known as “survivor guilt” and how they cope with the myriad of challenges beyond the physical that come with having cancer.
Survivor’s guilt can range from questions of “Why me?” and “Why did I survive?” to depression and even suicidal thoughts. Some may try to make sense of why they survived and others didn’t, while some people may feel guilty about the changes their families are going through. In its more extreme forms, survivor’s guilt is called Post Traumatic Stress Disorder (PTSD). Read more
Posted on April 27, 2017
After her mother passed away in 2008, Christina Granderson got serious about raising awareness. In addition to being a longtime Colon Cancer Alliance Buddy and advocate, she is part of the 70×2020 initiative in the state of Mississippi that has helped put her home state on the map as the first state to get a colon cancer prevention and screening vehicle tag! Thank you, Christina, for your never-ending devotion to stop this disease in honor of your beloved mom. We are inspired by everything you continue to achieve in her memory! Read more